BioLargo Inc.

BioLargo teamed up with Garratt-Callahan to co-create and develop a wastewater treatment product that will salvage usable water from commercial facilities, with full-scale units targeted for mid to late 2021 or early 2022.

BioLargo, Inc. and Garratt-Callahan Company announced a collaboration to co-create and develop a wastewater treatment product that will salvage usable water from commercial facilities. BioLargo will design, build and pilot a prototype, with full-scale units targeted for mid to late 2021 or early 2022.

BioLargo, Inc. completed manufacturing of its first-ever commercial-scale AOS water treatment unit, to be shipped to a municipal wastewater treatment plant near Montréal, Québec for a pilot project. The unit can treat up to 100 gallons per minute.

BioLargo, BKT, and Tomorrow Water finalized a joint venture to manufacture and distribute CupriDyne Clean odor and VOC control products in South Korea. BKT purchased $350,000 of BioLargo stock, and the joint venture is funded with $150,000 from BKT and Tomorrow Water and $100,000 from BioLargo.

BioLargo has executed a Joint Venture Framework Agreement with Bookang Tech Co. Ltd. (BKT) and its subsidiary Tomorrow Water to create a South Korean entity that will manufacture odor and VOC control products based on CupriDyne Clean. BioLargo will invest $100,000, while BKT and Tomorrow Water will invest $75,000 each.

BioLargo executed an agreement to form a joint venture with BKT Technologies of South Korea and its US subsidiary Tomorrow Water.

BioLargo Inc. formed a strategic alliance with BKT Company Limited (including its US subsidiary Tomorrow Water) and the City of Daegu, South Korea, to explore opportunities for BioLargo's water and wastewater treatment technologies in South Korea. The initial focus is on utilizing BioLargo's CupriDyne Clean Industrial Odor and VOC Eliminator in South Korea's wastewater treatment industry.